SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-121485
Filing Date
2021-04-20
Accepted
2021-04-19 18:05:29
Documents
3
Group Members
VERSANT AFFILIATES FUND V, L.P.VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.VERSANT VANTAGE I GP, L.P.VERSANT VANTAGE I GP-GP, LLCVERSANT VANTAGE I, L.P.VERSANT VENTURE CAPITAL V (CANADA) LPVERSANT VENTURES V (CANADA), L.P.VERSANT VENTURES V GP-GP (CANADA),

Document Format Files

Seq Description Document Type Size
1 SC 13D d151998dsc13d.htm SC 13D 199760
2 EX-1 d151998dex1.htm EX-1 12753
3 EX-2 d151998dex2.htm EX-2 59103
  Complete submission text file 0001193125-21-121485.txt   273544
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-7877
Versant Venture Capital V, L.P. (Filed by) CIK: 0001589097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 41 61 551 30 30
VectivBio Holding AG (Subject) CIK: 0001836379 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92481 | Film No.: 21835692
SIC: 2836 Biological Products, (No Diagnostic Substances)